PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.
Dogness Half Year Ended December 31, 2023 Revenue $6.7M VS $10.4M YoY
Financial Results for the Half Year Ended December 31, 2023Revenues decreased by approximately $3.7 million, or 35.8%, to approximately $6.7 million for the six months ended December 31, 2023 from approximately $10.4
